In accordance with the international recommendations, bone formation marker procollagen type I intact N-terminal propeptide (P1NP) and bone resorption marker collagen type I C-telopeptide (CTX) were generated using commercially available chemiluminescence protocols (Immunodiagnostics Systems, The Boldens, United Kingdom), as conducted previously ( 2.5 Covariate assessments Demographic and medical history (i.e., presence of selected comorbidities) were self-reported at baseline
The scientific evidence supports its benefits in metabolic health, cardiovascular health, brain function, and potentially longevity although this remains to be proven for humans
The synergistic effect of these two peptides results in increased production of growth hormone over an extended period, offering more substantial benefits compared to using either peptide alone
It is important to distinguish between evidence-based medical treatment for deficiency and unsubstantiated claims regarding weight management
Results guide your clinician toward the compound and starting dose most compatible with your biology, reducing side effects and accelerating weight-loss success without drug stacking